As of 2025-06-17, the Relative Valuation of ACADIA Pharmaceuticals Inc (ACAD) is 29.83 USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.14 USD, the upside of ACADIA Pharmaceuticals Inc based on Relative Valuation is 34.7%.
The range of the Relative Valuation is 23.56 - 39.77 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.2x - 21.9x | 21.3x |
| Forward P/E multiples | 13.8x - 22.0x | 16.9x |
| Fair Price | 23.56 - 39.77 | 29.83 |
| Upside | 6.4% - 79.6% | 34.7% |
| Date | P/E |
| 2025-06-13 | 15.87 |
| 2025-06-12 | 15.89 |
| 2025-06-11 | 16.30 |
| 2025-06-10 | 16.22 |
| 2025-06-09 | 16.30 |
| 2025-06-06 | 16.06 |
| 2025-06-05 | 15.60 |
| 2025-06-04 | 15.91 |
| 2025-06-03 | 16.06 |
| 2025-06-02 | 15.69 |
| 2025-05-30 | 15.76 |
| 2025-05-29 | 16.29 |
| 2025-05-28 | 16.09 |
| 2025-05-27 | 16.22 |
| 2025-05-23 | 16.06 |
| 2025-05-22 | 15.75 |
| 2025-05-21 | 15.97 |
| 2025-05-20 | 15.85 |
| 2025-05-19 | 16.07 |
| 2025-05-16 | 16.27 |
| 2025-05-15 | 12.86 |
| 2025-05-14 | 12.54 |
| 2025-05-13 | 12.57 |
| 2025-05-12 | 12.80 |
| 2025-05-09 | 12.75 |
| 2025-05-08 | 12.37 |
| 2025-05-07 | 10.82 |
| 2025-05-06 | 10.63 |
| 2025-05-05 | 11.06 |
| 2025-05-02 | 10.90 |
| 2025-05-01 | 10.65 |
| 2025-04-30 | 10.67 |
| 2025-04-29 | 10.55 |
| 2025-04-28 | 10.71 |
| 2025-04-25 | 10.77 |
| 2025-04-24 | 10.84 |
| 2025-04-23 | 10.68 |
| 2025-04-22 | 10.49 |
| 2025-04-21 | 10.51 |
| 2025-04-17 | 10.77 |
| 2025-04-16 | 10.65 |
| 2025-04-15 | 10.96 |
| 2025-04-14 | 10.86 |
| 2025-04-11 | 10.66 |
| 2025-04-10 | 10.31 |
| 2025-04-09 | 10.93 |
| 2025-04-08 | 10.30 |
| 2025-04-07 | 10.68 |
| 2025-04-04 | 11.24 |
| 2025-04-03 | 11.78 |